Your browser doesn't support javascript.
loading
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.
Batgi, Hikmettullah; Merdin, Alparslan; Dal, Mehmet Sinan; Kizil Çakar, Merih; Yildiz, Jale; Basçi, Semih; Uncu Ulu, Bahar; Yigenoglu, Tugçe Nur; Darçin, Tahir; Sahin, Derya; Bakirtas, Mehmet; Tetik, Aysegül; Iskender, Dicle; Altuntas, Fevzi.
Afiliación
  • Batgi H; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Merdin A; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Dal MS; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Kizil Çakar M; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Yildiz J; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Basçi S; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Uncu Ulu B; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Yigenoglu TN; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Darçin T; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Sahin D; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Bakirtas M; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Tetik A; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Iskender D; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Altuntas F; Department of Hematology and Stem Cell Transplantation Clinic, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
J Oncol Pharm Pract ; 26(8): 1857-1863, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32098553
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2020 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2020 Tipo del documento: Article País de afiliación: Turquía